Yufeng Shang

Publications

• Development of a Risk Assessment Model for Early Grade ≥ 3 Infection During the First 3 Months in Patients Newly Diagnosed With Multiple Myeloma Based on a Multicenter, Real-World Analysis in China
  Frontiers in Oncology. 2022  |   Pubmed ID: 35372017
• Evaluation of Prognostic Staging Systems of Multiple Myeloma in the Era of Novel Agents
  Hematological Oncology. Apr, 2022  |   Pubmed ID: 34860428
• Public Screening for COVID-19 in Wuhan, China and Beware of the Antibody Positive in Women and Tumor Patients
  Journal of Medical Virology. 04, 2022  |   Pubmed ID: 34850404
• Therapeutic Plateletpheresis in Patients With Thrombocytosis: Gender, Hemoglobin Before Apheresis Significantly Affect Collection Efficiency
  Frontiers in Medicine. 2021  |   Pubmed ID: 35004735
• Biological Characteristics of Umbilical Cord Mesenchymal Stem Cells and Its Therapeutic Potential for Hematological Disorders
  Frontiers in Cell and Developmental Biology. 2021  |   Pubmed ID: 34012958
• Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus
  Frontiers in Immunology. 2021  |   Pubmed ID: 33936026
• Factors Affecting Antibody Response to SARS-CoV-2 in Patients with Severe COVID-19
  Journal of Medical Virology. 02, 2021  |   Pubmed ID: 33289107
• Novel Biomarkers for the Prediction of COVID-19 Progression a Retrospective, Multi-center Cohort Study
  Virulence. 12, 2020  |   Pubmed ID: 33172355
• Scoring Systems for Predicting Mortality for Severe Patients with COVID-19
  EClinicalMedicine. Jul, 2020  |   Pubmed ID: 32766541
• TGF-β Receptor Inhibitor LY2109761 Enhances the Radiosensitivity of Gastric Cancer by Inactivating the TGF-β/SMAD4 Signaling Pathway
  Aging. 10, 2019  |   Pubmed ID: 31631064
• Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer
  Frontiers in Oncology. 2019  |   Pubmed ID: 31616632